Live Breaking News & Updates on Merck Co Inc Covid

Stay updated with breaking news from Merck co inc covid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Merck's Covid-19 pill does not cut hospitalisation, death rates in many vaccinated adults: Study

LONDON Merck & Co Inc's Covid-19 antiviral molnupiravir speeds up recovery but does not reduce the hospitalisation or death rate in higher-risk vaccinated adults, detailed data from a large study showed on Thursday (Dec 22). The drug, which prevents the virus from replicating, generated nearly US$5 billion (S$6.76 billion) in sales for the US drugmaker in the first three. ....

United Kingdom , City Of , Jonathan Van Tam , Ridgeback Biotherapeutics , Chris Butler , Paul Little , Merck Co Inc Covid , University Of Southampton , Britain National Health Service , Britain National Institute For Health , University Of Oxford , University Of Nottingham , National Health Service , National Institute , Care Excellence ,

Latest Articles

Latest Articles
freerepublic.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freerepublic.com Daily Mail and Mail on Sunday newspapers.

New York , United States , United Kingdom , Lasti Erfinanda , Donald Trump , Roman Curia , Wendell Husebo , Atezo Bev , Kelly Dietrich , Dario Perkins , Yehiai Mohamed , Doug Odonnell , Megan Henney , Audrey Gulick , Pope Francis , Serena Urry , Evans Dellon , Hannah Bleau , Anatoly Aksakov , Xpress Charit , Julie Kelly , Adriana Diaz , Kristen Hentschel , Madyson Dejausserand , Richard Nixon , Michael Snyder ,

WHO recommends Merck's Covid-19 pill for high-risk patients

A World Health Organisation (WHO) panel on Wednesday (March 2) backed the use of Merck & Co Inc's Covid-19 antiviral pill for high-risk patients. The expert panel conditionally recommended the pill, molnupiravir, for patients with non-severe disease who are at high risk of hospitalisation, such as the immunocompromised, the unvaccinated, older people and those with chronic diseases. The recommendation was. ....

United Kingdom , Eli Lilly , Merck Co Inc Covid , A World Health Organisation , Guideline Development Group , Pfizer Inc , Regeneron Pharmaceuticals Inc Covid , World Health Organisation , Development Group , British Medical Journal , Regeneron Pharmaceuticals Inc , Vir Biotechnology ,